Joshua Aiello - 08 May 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Principal Accounting Officer
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
08 May 2024
Net transactions value
$0
Form type
4
Filing time
10 May 2024, 17:24:07 UTC
Previous filing
24 Jul 2023
Next filing
28 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option (Right to Buy) Award $0 +42,000 $0.000000 42,000 08 May 2024 Common Stock 42,000 $4.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest as follows: (i) 10,500 of the stock options will vest on May 8, 2025 (the "Vesting Date") and (ii) the remaining 31,500 stock options will vest in equal installments every three months on the same day of the month as the Vesting Date, starting on August 8, 2025, subject to the Reporting Person's continuous service through such dates.